Biotechnology Market Research Reports
Sort By
| Title | Published | Price | Buy Now |
|---|---|---|---|
| CD40 Agonist - Pipeline Insight, 2019
By Delve Insight
"CD40 Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD40 Agonist development. The report provides detailed coverage of the... |
Jan 2019 | $ 1250 | |
| Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cell Division Cycle 7... |
Jan 2019 | $ 1250 | |
| Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Checkpoint Kinase 1 (Chk1) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Checkpoint Kinase 2 (Chk2) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase Inhibitor development. Th... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase 1 (CDK1) Inhibit... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase 2 (CDK2) Inhibit... |
Jan 2019 | $ 1250 | |
| Cyclophilin Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclophilin Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclophilin Inhibitor development. The report provides detail... |
Jan 2019 | $ 1250 | |
| Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cystic Fibrosi... |
Jan 2019 | $ 1250 | |
| Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cytochrome P450 17 (CYP17) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Diglyceride Acyltransferase (DGAT) Inh... |
Jan 2019 | $ 1250 | |
| Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Dihydroorotate Dehydrogenase (DHODH)... |
Jan 2019 | $ 1250 | |
| DNA Methyltransferase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA Methyltransferase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA Methyltransferase Inhibitor development. The re... |
Jan 2019 | $ 1250 | |
| DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA-Dependent RNA Polymerase Inhibitor devel... |
Jan 2019 | $ 1250 | |
| DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019
By Delve Insight
"DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeut... |
Jan 2019 | $ 1250 | |
| Eg5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Eg5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Eg5 Inhibitor development. The report provides detailed coverage of t... |
Jan 2019 | $ 1250 | |
| Elastase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Elastase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Elastase Inhibitor development. The report provides detailed cov... |
Jan 2019 | $ 1250 | |
| Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor (ET) Antagonist development... |
Jan 2019 | $ 1250 | |
| Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor A (ETA) Antagonist devel... |
Jan 2019 | $ 1250 | |
| Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Enhancer of zeste homolog 2 (EZH2) Inh... |
Jan 2019 | $ 1250 | |
| Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Ephrin Type A Recept... |
Jan 2019 | $ 1250 | |
| Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Epithelial Sodium Channel (ENaC) Inhibit... |
Jan 2019 | $ 1250 | |
| Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019
By Delve Insight
"Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Estrogen Receptor Beta Partial Agonist devel... |
Jan 2019 | $ 1250 | |
| Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor II (Prothrombin) Inhibitor development. Th... |
Jan 2019 | $ 1250 | |
| Factor IX - Pipeline Insight, 2019
By Delve Insight
"Factor IX - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX development. The report provides detailed coverage of the pipel... |
Jan 2019 | $ 1250 |